News | November 05, 2010

Cardiovascular Systems Settles Lawsuit With ev3 for $1 Million

November 5, 2010 – Cardiovascular Systems Inc. (CSI) will pay $1 million to settle an employment lawsuit with ev3, which is now part of Covidien.

The litigation stems from a lawsuit ev3 originally filed in 2007 related to ev3 employees who joined Cardiovascular Systems Inc.

Neither party admits any liability or wrongdoing. Both companies develop transcatheter atherectomy devices for use in peripheral artery disease (PAD).

For more information: www.csi360.com


Additional Content

News | Atherectomy Devices

Medtronic recently announced results from two studies evaluating the utility of atherectomy for peripheral endovascular ...

Home November 08, 2024
Home
News | Atherectomy Devices

February 15, 2023 — Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to ...

Home February 15, 2023
Home
News | Atherectomy Devices

July 28, 2022 — Northeast Scientific Inc., pioneers in reprocessing single use peripheral vascular catheters, announced ...

Home July 28, 2022
Home
News | Atherectomy Devices

March 9, 2022 — Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design ...

Home March 09, 2022
Home
News | Atherectomy Devices

January, 24, 2022 — Medtronic Inc. is recalling its HawkOne Directional Atherectomy System product due to the risk of ...

Home January 24, 2022
Home
Subscribe Now